YAP/TAZ inhibitor-1
YAP/TAZ inhibitor-1 is a YAP/TAZ inhibitor extracted from patent WO2017058716A1, Compound 1, has an IC50 of [1].
Product Specifications
CAS Number
2093565-23-0
UNSPSC
12352005
Target
YAP
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/yap-taz-inhibitor-1.html
Purity
99.72
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=S(C1=CC2=C(C=C1)C3=C(C=C(S(=O)(C4CCC(C)(C)CC4)=O)C=C3)/C2=N\O)(N5CCN(C(C6=CC=CC=C6)C)CC5)=O
Molecular Formula
C33H39N3O5S2
Molecular Weight
621.81
References & Citations
[1]Tracy Tzu-Ling Tang Lin, et al. Tricyclic compounds. WO2017058716A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
YAP/TAZ
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680270-500 1x 500 µL
Fibronectin (HFN7.1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740630-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
